Correlation Between Collegium Pharmaceutical and Flora Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Flora Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Flora Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Flora Growth Corp, you can compare the effects of market volatilities on Collegium Pharmaceutical and Flora Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Flora Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Flora Growth.

Diversification Opportunities for Collegium Pharmaceutical and Flora Growth

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Collegium and Flora is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Flora Growth Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flora Growth Corp and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Flora Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flora Growth Corp has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Flora Growth go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Flora Growth

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 1.43 times less return on investment than Flora Growth. But when comparing it to its historical volatility, Collegium Pharmaceutical is 3.69 times less risky than Flora Growth. It trades about 0.01 of its potential returns per unit of risk. Flora Growth Corp is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  478.00  in Flora Growth Corp on October 9, 2024 and sell it today you would lose (371.00) from holding Flora Growth Corp or give up 77.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Collegium Pharmaceutical  vs.  Flora Growth Corp

 Performance 
       Timeline  
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Flora Growth Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Flora Growth Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Collegium Pharmaceutical and Flora Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collegium Pharmaceutical and Flora Growth

The main advantage of trading using opposite Collegium Pharmaceutical and Flora Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Flora Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flora Growth will offset losses from the drop in Flora Growth's long position.
The idea behind Collegium Pharmaceutical and Flora Growth Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance